Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
JTEC Corp/Osaka (3446 JP)
Watchlist
16
Analysis
Health Care
•
Japan
JTEC Corporation of Osaka manufactures bio-technology systems and equipment. The Company produces life science devices, x ray mirrors, and automated cell culture systems. JTEC also develops pharmaceutical products. JTEC serves clients in Japan.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JTEC Corp/Osaka
•
28 May 2024 19:36
•
Issuer-paid
JTEC Corp (3446) - Facing Some Challenges over Lead Times
Lengthening order lead times impacting revenue recognition – Q1-3 FY6/24 results were behind expectations in our view, with sales declining 27.6% YoY.
Astris Advisory Japan
Follow
398 Views
Share
bullish
•
JTEC Corp/Osaka
•
16 Apr 2024 19:45
•
Issuer-paid
JTEC Corp (3446) - Embarking on a Multi-Year Runway of Growth with Technological Advantage
JTEC Corp is a specialist technology innovator, and a global market leader in customized X-ray mirrors used in synchrotron radiation and X-ray free...
Astris Advisory Japan
Follow
326 Views
Share
bullish
•
Quantitative Analysis
•
30 Nov 2020 09:44
TOPIX Inclusion Trade Summary: Nov 2020
November review of pre-events, live events, and post-events in the TOPIX Inclusion trade universe. There are a dozen pre-event recommendations...
Janaghan Jeyakumar, CFA
Follow
484 Views
Share
bullish
•
Quantitative Analysis
•
29 Oct 2020 17:35
TOPIX Inclusion Trade Summary: Oct 2020
TOPIX Inclusion Trade summary for October 2020. "Live" events, "Completed" events, and the unwind of the Post-IPO Basket Trade Strategy due to TSE...
Janaghan Jeyakumar, CFA
Follow
520 Views
Share
bullish
•
Quantitative Analysis
•
29 Sep 2020 21:11
TOPIX Inclusion Trade Summary: Sep 2020
The Tokyo Stock Exchange will be introducing new requirement
Janaghan Jeyakumar, CFA
Follow
518 Views
Share
First
Previous
1
2
3
4
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x